BENGALURU/NEW DELHI (Reuters) – India, the world’s main supplier of generic drugs, has restricted the export of 26 pharmaceutical ingredients and the medicines made from them, including paracetamol, as the coronavirus outbreak plays havoc with supply chains. Indian drugmakers rely on China, the source of the virus outbreak, for almost 70% of the active pharmaceutical ingredients (APIs) for their medicines. “Export of specified APIs and formulations made from these APIs… is hereby ‘restricted’ with immediate effect and till further orders,” the Director General of Foreign Trade said in a statement https://dgft.gov.in/sites/default/files/Noti%2050_0.pdf on Tuesday, without explaining the extent of the restrictions.
